Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Japan Medical Dynamic Marketing, INC. (JMDMF)

Compare
3.3400
0.0000
(0.00%)
At close: April 4 at 4:00:00 PM EDT
Loading Chart for JMDMF
  • Previous Close 0.0000
  • Open 11.7500
  • Bid 2.6300 x --
  • Ask 3.6300 x --
  • Day's Range 4.7000 - 4.7000
  • 52 Week Range 3.3400 - 11.7500
  • Volume 113,150
  • Avg. Volume 81
  • Market Cap (intraday) 91.376M
  • Beta (5Y Monthly) 0.48
  • PE Ratio (TTM) 9.03
  • EPS (TTM) 0.3700
  • Earnings Date Apr 30, 2025
  • Forward Dividend & Yield 0.19 (5.62%)
  • Ex-Dividend Date Mar 28, 2025
  • 1y Target Est --

Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices for the use in spinal instability surgery; and artificial bone fillers for the treatment of bone fractures, tumors, and other defects. It offers its products to doctors and hospitals. The company was incorporated in 1973 and is headquartered in Shinjuku, Japan.

www.jmdm.co.jp

511

Full Time Employees

March 31

Fiscal Year Ends

Recent News: JMDMF

View More

Performance Overview: JMDMF

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

JMDMF
134.05%
Nikkei 225 (^N225)
15.81%

1-Year Return

JMDMF
115.04%
Nikkei 225 (^N225)
14.85%

3-Year Return

JMDMF
721.80%
Nikkei 225 (^N225)
25.22%

5-Year Return

JMDMF
75.13%
Nikkei 225 (^N225)
72.25%

Compare To: JMDMF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: JMDMF

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    91.38M

  • Enterprise Value

    94.03M

  • Trailing P/E

    9.14

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.53

  • Price/Book (mrq)

    0.49

  • Enterprise Value/Revenue

    0.55

  • Enterprise Value/EBITDA

    4.27

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.75%

  • Return on Assets (ttm)

    3.50%

  • Return on Equity (ttm)

    5.66%

  • Revenue (ttm)

    24.64B

  • Net Income Avi to Common (ttm)

    1.42B

  • Diluted EPS (ttm)

    0.3700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.33B

  • Total Debt/Equity (mrq)

    10.13%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: JMDMF

View More

Company Insights: JMDMF

Research Reports: JMDMF

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.